Last reviewed · How we verify
NCT04947891
The Establishment of the Integration of Surgery and Postoperative Intensive Recovery of Patients With CSM
trial testing Intensive recovery management in Cervical Myelopathy in 130 participants. Completed in 20 December 2020.
15 June 2020
Quick facts
| Lead sponsor | Peking University Third Hospital |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 130 |
| Start date | 6 December 2017 |
| Primary completion | 15 June 2020 |
| Estimated completion | 20 December 2020 |
| Sites | 1 location across China |
Drugs / interventions tested
- Intensive recovery management
Conditions studied
- Cervical Myelopathy — all drugs for Cervical Myelopathy →
- Ossification of Posterior Longitudinal Ligament in Cervical Region — all drugs for Ossification of Posterior Longitudinal Ligament in Cervical Region →
Sponsor
Peking University Third Hospital
Who can join
Adults 17 to 80, any sex, with Cervical Myelopathy or Ossification of Posterior Longitudinal Ligament in Cervical Region. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This study aims to establish the specialist consensus of the integration of posterior approach surgical treatment and postoperative intensive recovery management for CSM or OPLL patients, and verify its safety, practicability and reliability.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT04947891
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Cervical Myelopathy
Currently open trials in the same condition.
- NCT06893406 — Cervical Myelopathy in Hip Fracture Patients · NA · recruiting
- NCT06701422 — Targeting Cervical Epidural Spinal Cord Stimulation for Functional Recovery · NA · recruiting
- NCT06520020 — Evaluating Safety and Feasibility of Transcutaneous Spinal Cord Stimulation Following Traumatic and Non-Traumatic Spinal · NA · recruiting
- NCT06486038 — Quatitative MRI of the Spinal Cord in Cervical Myelopathy: Assessment of Microstuctural Damage for Outcome Improvement · NA · recruiting
- NCT05183971 — Proprioceptive Deficits in Degenerative Cervical Myelopathy · recruiting
Other Peking University Third Hospital trials
Trials by the same sponsor.
- NCT07532421 — Probiotic Intervention on the Development of Allergic Diseases in Infants Exposed to Antibiotics Early in Life · NA · not yet recruiting
- NCT07470255 — Detection of Diabetic Foot Skin Damage Using Plantar Mechanical Parameters · not yet recruiting
- NCT07453381 — Multisensor Wireless Pressure Microcatheter For Microvascular Function Assessment In ANOCA/INOCA Patients: A Prospective · not yet recruiting
- NCT07452354 — AI-Based Diabetic Foot Recurrence Cohort · not yet recruiting
- NCT07423819 — Sports Rehabilitation Therapy for Knee Joint Sports Injuries: A Case Study of Anterior Cruciate Ligament Injury and Pate · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04947891 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Peking University Third Hospital
- Last refreshed: 1 July 2021
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04947891.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing